V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330011437 | 330010463 | 1.73 | 121.6 | Adjuvant (A) | 2016-01-03 | 2016-02-29 | OST Euramos 1 Closed Trial - M | N | N | 330008733 | METHOTREXATE HIGH DOSE |
| 330011438 | 330004092 | 0 | 61 | Curative (C) | 2013-06-21 | 2013-07-31 | Carboplatin AUC 2 - 5 | N | N | 330008764 | CARBOPLATIN |
| 330011439 | 330013029 | 1.73 | 70 | Palliative (P) | 2018-09-30 | 2018-10-15 | Carboplatin AUC 6 - 10 | N | N | 330008805 | CARBOPLATIN |
| 330011440 | 330008232 | null | null | Palliative (P) | 2017-12-13 | 2018-02-08 | Carboplatin AUC 6 - 10 | 02 | N | 330008810 | CARBOPLATIN |
| 330011441 | 330004098 | null | 107 | Palliative (P) | null | 2017-08-05 | Rituximab | Y | N | 330008821 | RITUXIMAB |
| 330011442 | 330004102 | 1.77 | 115.9 | Curative (C) | null | 2016-04-11 | CETUXIMAB | N | N | 330008865 | CETUXIMAB |
| 330011443 | 330004103 | 1.78 | 61.6 | Curative (C) | 2015-07-22 | 2015-08-05 | Rituximab | 2 | N | 330008887 | RITUXIMAB |
| 330011444 | 330008240 | 1.65 | 79.4 | Curative (C) | 2016-09-30 | 2016-11-02 | Rituximab (Maintenance) | 02 | N | 330008905 | RITUXIMAB |
| 330011447 | 330004116 | 1.69 | 82 | Neo-adjuvant (N) | null | 2016-01-24 | Etoposide + Ifosfamide (3 days) | 1 | N | 330008951 | ETOPOSIDE + IFOSFAMIDE |
| 330011448 | 330004120 | 1.51 | 64.4 | Adjuvant (A) | 2018-01-02 | 2018-01-02 | MAP | N | N | 330008953 | MAP |
| 330011449 | 330004122 | null | 101 | Curative (C) | 2018-02-12 | 2018-02-28 | ETOPOSIDE + IFOSFAMIDE | 02 | N | 330008977 | ETOPOSIDE + IFOSFAMIDE |
| 330011450 | 330004125 | 1.68 | 70.8 | Curative (C) | 2017-02-04 | 2017-02-04 | OST Euramos 1 Closed Trial - AP | N | Y | 330008977 | MAP |
| 330011451 | 330004129 | 1.68 | 56.5 | Adjuvant (A) | 2014-02-14 | 2014-12-02 | MAP | N | N | 330009031 | MAP |
| 330011452 | 330004133 | 1.64 | null | Palliative (P) | 2016-05-02 | 2016-07-24 | Carboplatin AUC 6 - 10 | N | null | 330009044 | CARBOPLATIN |
| 330011455 | 330004142 | 1.67 | null | Neo-adjuvant (N) | null | 2015-02-04 | Methotrexate High Dose (3g/m2) | null | null | 330009101 | METHOTREXATE HIGH DOSE |
| 330011456 | 330004146 | 0 | 87.9 | Palliative (P) | 2015-03-10 | 2015-03-27 | Methotrexate High Dose (3g/m2) | 02 | N | 330009102 | METHOTREXATE HIGH DOSE |
| 330011457 | 330004152 | 1.9 | 85.9 | Palliative (P) | 2018-10-26 | 2018-11-01 | ETOPOSIDE + IFOSFAMIDE | 2 | N | 330009140 | ETOPOSIDE + IFOSFAMIDE |
| 330011458 | 330008272 | 1.67 | 82.6 | Curative (C) | 2015-09-16 | 2015-09-21 | Carboplatin AUC 2 - 5 | N | N | 330009169 | CARBOPLATIN |
| 330011459 | 330004160 | 1.83 | 62 | Neo-adjuvant (N) | 2017-05-23 | 2017-06-19 | CISPLATIN + FLUOROURACIL | N | N | 330009184 | CISPLATIN + FLUOROURACIL |
| 330011460 | 330004166 | 1.85 | 73.6 | Palliative (P) | 2013-07-15 | 2013-08-22 | Etoposide + Ifosfamide (3 days) | N | N | 330009223 | ETOPOSIDE + IFOSFAMIDE |
| 330011461 | 330004170 | 1.72 | 42.7 | Palliative (P) | 2012-06-24 | 2013-05-24 | Methotrexate High Dose (3g/m2) | N | N | 330009253 | METHOTREXATE HIGH DOSE |
| 330011464 | 330004196 | 1.77 | 150.4 | Palliative (P) | 2016-02-20 | 2016-03-27 | Etoposide + Ifosfamide (3 days) | N | N | 330009437 | ETOPOSIDE + IFOSFAMIDE |
| 330011465 | 330008297 | 1.75 | 88 | Adjuvant (A) | 2015-05-29 | 2015-06-30 | MAP | N | N | 330009445 | MAP |
| 330011466 | 330004200 | null | null | Not known (9) | 2017-09-15 | 2017-10-13 | DOCETAXEL + GEMCITABINE | N | N | 330009446 | DOCETAXEL + GEMCITABINE |
| 330011467 | 330004206 | 1.79 | 76.599 | Curative (C) | 2017-10-27 | 2018-04-14 | ETOPOSIDE + IFOSFAMIDE | N | N | 330009744 | ETOPOSIDE + IFOSFAMIDE |
| 330011468 | 330004212 | 1.89 | 83.4 | Curative (C) | 2017-05-10 | 2017-06-10 | CISPLATIN + FLUOROURACIL | null | N | 330009753 | CISPLATIN + FLUOROURACIL |
| 330011469 | 330004215 | 1.83 | 82.6 | Adjuvant (A) | 2015-07-30 | 2015-08-06 | CARBOPLATIN | N | N | 330009847 | CARBOPLATIN |
| 330011470 | 330004218 | 1.81 | 79.5 | Palliative (P) | 2016-01-07 | 2016-11-04 | OST Euramos 1 Closed Trial - M | 02 | N | 330009871 | METHOTREXATE HIGH DOSE |
| 330011471 | 330008307 | 1.75 | 111.3 | Neo-adjuvant (N) | 2018-04-03 | 2018-04-03 | Docetaxel + Gemcitabine (prior RT) | N | N | 330010223 | DOCETAXEL + GEMCITABINE |
| 330011472 | 330004225 | null | 78.8 | Curative (C) | 2013-11-12 | 2013-12-02 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 330010467 | CETUXIMAB |
| 330011473 | 330004226 | 1.68 | 60 | Palliative (P) | 2016-02-03 | 2016-06-06 | Cetuximab 7 day (>Cycle 2) | 02 | N | 330010479 | CETUXIMAB |
| 330011474 | 330004227 | 0 | 44.2 | Not known (9) | 2018-03-10 | 2018-06-16 | MAP | 02 | null | 330010484 | MAP |
| 330011477 | 330010511 | 0 | 54 | Palliative (P) | 2016-09-08 | 2016-09-08 | Docetaxel + Gemcitabine (prior RT) | N | null | 330010672 | DOCETAXEL + GEMCITABINE |
| 330011478 | 330004244 | 1.7 | 105.5 | Curative (C) | 2017-05-20 | 2017-06-03 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 330010681 | RITUXIMAB |
| 330011479 | 330004244 | 1.7 | 91.4 | Palliative (P) | 2017-11-20 | 2018-01-01 | Docetaxel + Gemcitabine with GCSF | 02 | N | 330010681 | DOCETAXEL + GEMCITABINE |
| 330011480 | 330004247 | 1.61 | 63.6 | Palliative (P) | 2014-09-03 | 2014-09-17 | Docetaxel+Gemcitabine (no prior RT) | null | null | 330010701 | DOCETAXEL + GEMCITABINE |
| 330011481 | 330004251 | 1.7 | 87.35 | Neo-adjuvant (N) | 2014-08-30 | 2015-05-29 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 330010712 | CISPLATIN + FLUOROURACIL |
| 330011482 | 330008328 | 1.8 | 108 | Adjuvant (A) | 2017-05-12 | 2017-06-21 | Methotrexate High Dose (3g/m2) | 02 | Y | 330010739 | METHOTREXATE HIGH DOSE |
| 330011483 | 330008328 | 1.54 | 102.1 | Curative (C) | 2018-08-10 | 2018-08-25 | Rituximab | N | N | 330010739 | RITUXIMAB |
| 330011484 | 330004259 | 1.62 | 106 | Disease modification (D) | 2015-07-24 | 2015-11-16 | Rituximab | N | N | 330010826 | RITUXIMAB |
| 330011485 | 330004260 | 1.81 | 53 | Curative (C) | 2017-07-23 | 2017-07-24 | Etoposide + Ifosfamide (3 days) | 02 | N | 330010836 | ETOPOSIDE + IFOSFAMIDE |
| 330011486 | 330010519 | 1.73 | 150.4 | Palliative (P) | 2018-04-19 | 2018-05-02 | CETUXIMAB | N | N | 330010845 | CETUXIMAB |
| 330011487 | 330013033 | 1.61 | 79.4 | Neo-adjuvant (N) | 2016-04-27 | 2016-05-02 | MAP | N | null | 330010873 | MAP |
| 330011488 | 330004266 | 1.66 | 24.6 | Neo-adjuvant (N) | 2017-12-12 | 2018-03-23 | MAP | 02 | N | 330010883 | MAP |
| 330011489 | 330004270 | 1.72 | 82.4 | Neo-adjuvant (N) | 2016-02-05 | 2016-03-18 | MAP | N | N | 330010902 | MAP |
| 330011490 | 330012414 | 1.92 | 62 | Curative (C) | 2018-10-29 | 2018-10-29 | Rituximab (INTRAVENOUS Maintenance) | Y | N | 330010903 | RITUXIMAB |
| 330011491 | 330012414 | 1.65 | 36.1 | Curative (C) | 2017-05-15 | 2017-05-18 | CETUXIMAB | N | N | 330010903 | CETUXIMAB |
| 330011492 | 330008338 | 1.81 | 106.5 | Neo-adjuvant (N) | 2018-05-29 | 2018-05-30 | Methotrexate High Dose (3g/m2) | N | N | 330010929 | METHOTREXATE HIGH DOSE |
| 330011494 | 330010523 | null | null | Curative (C) | 2016-12-06 | 2016-12-09 | Carboplatin AUC 6 - 10 | null | null | 330010974 | CARBOPLATIN |
| 330011495 | 330004288 | null | null | Palliative (P) | 2018-02-10 | 2018-03-12 | DOCETAXEL + GEMCITABINE | N | N | 330010979 | DOCETAXEL + GEMCITABINE |